Literature DB >> 6602162

Upper gastrointestinal bleeding in patients with portal hypertension: a reappraisal.

P Dave, J Romeu, J Messer.   

Abstract

The current medical literature states that upper gastrointestinal bleeding in patients with cirrhosis and portal hypertension originates from a variety of sources. Although variceal bleeding has been recognized as the principal source, acute erosive gastritis and peptic ulcer are said to be the bleeding site in a large percentage of cases. In 140 consecutive patients with endoscopically documented esophageal varices who came to our service with upper gastrointestinal hemorrhage, varices were the source of bleeding in approximately 90%, regardless of whether the underlying liver disease was due to alcoholism or not. We conclude that: 1) patients with varices almost always bleed from varices, and 2) the incidence of erosive gastritis and peptic ulcer as a cause of bleeding in this group has been overemphasized.

Entities:  

Mesh:

Year:  1983        PMID: 6602162     DOI: 10.1097/00004836-198304000-00004

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

Review 1.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

2.  A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.

Authors:  W Yeo; J Y Sung; S C Ward; S C Chung; W Y Lee; A K Li; P J Johnson
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

3.  Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction.

Authors:  S K Sarin; G Sachdev; R Nanda
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

4.  Upper gastrointestinal bleeding in patients with liver cirrhosis.

Authors:  Olajide O Odelowo; Duane T Smoot; Kyungsook Kim
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.